Combination treatment for BPH approved
Tamsulosin and dutasteride combination approved by FDA.
Combination treatment with the alpha blocker tamsulosin (Flomax, Boehringer Ingelheim) and 5-alpha reductase inhibitor dutasteride (Avodart, GSK) has received approval for a new indication: treatment of symptomatic enlarged prostate or benign prostatic hyperplasia (BPH). The approval was based on results from the CombAT (Combination of Avodart and Tamsulosin) trial which showed use of both drugs was superior to both monotherapies at 12 months and continued up through 24 months. Efficacy was measured as a reduction in the International Prostate Symptom Score (IPSS).
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety
December 13th 2024A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.
